International Journal of Drug Policy
Volume 13, Issue 2 , Pages 85-94, June 2002

The ‘risk environment’: a framework for understanding and reducing drug-related harm

  • Tim Rhodes

      Affiliations

    • Corresponding Author InformationTel.: +44-20-7584-0791; fax: +44-20-7594-0866

The Centre for Research on Drugs and Health Behaviour, Imperial College, University of London, UK

Abstract 

Public discourses on health increasingly emphasise the environment. While harm reduction has developed in parallel with the new public health movement, and both seek to encourage risk reduction by promoting individual and community action as well as environmental change, there remains an over reliance on individualistic modes of behaviour change. This commentary offers the concept of the ‘risk environment’ as a potentially useful framework for understanding and reducing drug-related harm, especially HIV infection associated with drug injection. It is argued that a shift in focus towards the ‘risk environment’ as a unit of analysis and change helps to overcome the limits of individualism characterising most HIV prevention interventions as well as to appreciate how drug-related harm intersects with health and vulnerability more generally. This in turn raises the importance of ‘non-drug’ and ‘non-health’ interventions for harm reduction and the facilitation of alliances between harm reduction and other social movements oriented to tackling vulnerability as a means of promoting public health.

Keywords:  Risk environment, Injecting drug use, Structural factors, HIV prevention

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0955-3959(02)00007-5

International Journal of Drug Policy
Volume 13, Issue 2 , Pages 85-94, June 2002